chr1-196654207-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000186.4(CFH):​c.58+2032T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 152,072 control chromosomes in the GnomAD database, including 1,798 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 1798 hom., cov: 32)

Consequence

CFH
NM_000186.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.18

Publications

19 publications found
Variant links:
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]
CFH Gene-Disease associations (from GenCC):
  • C3 glomerulonephritis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • atypical hemolytic-uremic syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • basal laminar drusen
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hemolytic uremic syndrome, atypical, susceptibility to, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complement factor H deficiency
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Doyne honeycomb retinal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dense deposit disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.167 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000186.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFH
NM_000186.4
MANE Select
c.58+2032T>C
intron
N/ANP_000177.2
CFH
NM_001014975.3
c.58+2032T>C
intron
N/ANP_001014975.1A0A0D9SG88

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFH
ENST00000367429.9
TSL:1 MANE Select
c.58+2032T>C
intron
N/AENSP00000356399.4P08603
ENSG00000289697
ENST00000696032.1
c.58+2032T>C
intron
N/AENSP00000512341.1A0A8Q3SIA1
CFH
ENST00000630130.2
TSL:1
c.58+2032T>C
intron
N/AENSP00000487250.1A0A0D9SG88

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
22835
AN:
151952
Hom.:
1792
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.191
Gnomad EAS
AF:
0.0397
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.137
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.156
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.150
AC:
22863
AN:
152072
Hom.:
1798
Cov.:
32
AF XY:
0.147
AC XY:
10950
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.171
AC:
7084
AN:
41490
American (AMR)
AF:
0.126
AC:
1918
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.191
AC:
660
AN:
3464
East Asian (EAS)
AF:
0.0395
AC:
205
AN:
5184
South Asian (SAS)
AF:
0.101
AC:
486
AN:
4830
European-Finnish (FIN)
AF:
0.137
AC:
1452
AN:
10594
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.156
AC:
10593
AN:
67912
Other (OTH)
AF:
0.157
AC:
331
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
979
1957
2936
3914
4893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.152
Hom.:
7097
Bravo
AF:
0.152
Asia WGS
AF:
0.124
AC:
429
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.89
DANN
Benign
0.83
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7524776; hg19: chr1-196623337; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.